Expanding the Armamentarium in Metastatic Liver Cancer

EP. 1: Trends and Risk Factors in Liver Cancer

February 23rd 2018

EP. 2: HCC: Multidisciplinary Decision-Making

February 23rd 2018

EP. 3: Response and Outcomes With TKIs in HCC

February 23rd 2018

EP. 4: Second-Line Nivolumab in Liver Cancer

February 23rd 2018

EP. 5: HCC: Considerations in Toxicity Management

February 23rd 2018

EP. 6: Proactive Management of TKI Side Effects in HCC

February 23rd 2018

EP. 7: HCC: Nivolumab's Side Effects

February 23rd 2018

EP. 8: Sequencing Considerations in HCC

February 23rd 2018

EP. 9: Frontline Clinical Trials in Liver Cancer

February 23rd 2018

EP. 10: Emerging Second-Line Therapies in HCC

February 23rd 2018

EP. 11: Novel Combinations on the Horizon in HCC

February 23rd 2018

EP. 12: Growing Treatment Landscape in Liver Cancer

February 23rd 2018

EP. 13: Managing Locoregional Therapies in HCC

February 23rd 2018

EP. 14: Locoregional Therapies for Extrahepatic HCC

February 23rd 2018

EP. 15: Interventional Radiology and More for HCC

February 23rd 2018